Cargando…
FRI171 Can 11-Dehydrodexamethasone Improve The Salivary Dexamethasone Suppression Test?
Disclosure: D. Marshall: None. B.G. Issa: None. B.G. Keevil: None. Background: The 1 mg overnight dexamethasone suppression test (ONDST) is recommended as a first-line test for the investigation of Cushing Syndrome. Measurement of dexamethasone alongside cortisol in a 9am serum sample has been credi...
Autores principales: | Marshall, David, Issa, Basil George, Keevil, Brian George |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554652/ http://dx.doi.org/10.1210/jendso/bvad114.166 |
Ejemplares similares
-
FRI172 Assessment Of Plasma Dexamethasone Levels After 1-mg Dexamethasone Suppression Test In Adults With Obesity
por: Paopongpaiboon, Pimonrat, et al.
Publicado: (2023) -
OR30-01 Waking Salivary 11-hydroxyandrostenedione And Cortisone As A Novel Non-invasive Test For Adrenal Insufficiency
por: Lawrence, Neil Richard, et al.
Publicado: (2023) -
FRI200 Severe Cushing Syndrome Due To An ACTH-producing Pheochromocytoma
por: Stamatiades, George Alexiades, et al.
Publicado: (2023) -
FRI230 Cystic Pheochromocytoma
por: Saberi, Sima
Publicado: (2023) -
FRI223 Ectopic ACTH Syndrome
por: Sudhakar, Shwetha Mallesara, et al.
Publicado: (2023)